Found: 31
Select item for more details and to access through your institution.
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 4, p. 572, doi. 10.1007/s13365-020-00860-1
- By:
- Publication type:
- Article
Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 6, p. 842, doi. 10.1515/cclm-2022-0007
- By:
- Publication type:
- Article
Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reply to "Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population".
- Published in:
- Annals of Neurology, 2020, v. 87, n. 1, p. 155, doi. 10.1002/ana.25633
- By:
- Publication type:
- Article
Reply to "Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population".
- Published in:
- 2019
- By:
- Publication type:
- letter
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy.
- Published in:
- 2019
- By:
- Publication type:
- letter
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8519, doi. 10.3390/ijms21228519
- By:
- Publication type:
- Article
Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 4, p. 1, doi. 10.1177/2055217318819535
- By:
- Publication type:
- Article
Serum Neurofilament light correlates with CADASIL disease severity and survival.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 1, p. 46, doi. 10.1002/acn3.678
- By:
- Publication type:
- Article
Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 4, p. 1, doi. 10.1002/dad2.12496
- By:
- Publication type:
- Article
The global Alzheimer's Association round robin study on plasma amyloid β methods.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12242
- By:
- Publication type:
- Article
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease Continuum.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 437, doi. 10.2967/jnumed.122.264279
- By:
- Publication type:
- Article
A head-to-head comparison between plasma pTau181 and tau-PET along the Alzheimer's disease continuum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264279
- By:
- Publication type:
- Article
Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 11, p. 1832, doi. 10.1002/acn3.51676
- By:
- Publication type:
- Article
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01545-1
- By:
- Publication type:
- Article
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01409-8
- By:
- Publication type:
- Article
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.
- Published in:
- NPJ Aging, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41514-023-00114-4
- By:
- Publication type:
- Article
Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years.
- Published in:
- Brain Communications, 2023, v. 5, n. 1, p. 1, doi. 10.1093/braincomms/fcad024
- By:
- Publication type:
- Article
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 11, p. 1375, doi. 10.1001/jamaneurol.2021.3180
- By:
- Publication type:
- Article
Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer's disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89004-x
- By:
- Publication type:
- Article
Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00738-8
- By:
- Publication type:
- Article
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00728-w
- By:
- Publication type:
- Article
Combination of plasma amyloid beta<sub>(1-42/1-40)</sub> and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13195-020-00682-7
- By:
- Publication type:
- Article
Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART-MR Study.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 4, p. 1, doi. 10.1161/JAHA.123.032134
- By:
- Publication type:
- Article
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-020-01137-1
- By:
- Publication type:
- Article
Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2453, doi. 10.1002/alz.13687
- By:
- Publication type:
- Article
Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 8, p. 1484, doi. 10.1002/alz.12510
- By:
- Publication type:
- Article